Key facts
- Notable investors include Euclid Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Riviera
- ·The full record, as it builds
Funding rounds
No funding rounds for Riviera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Riviera
Developer of an AI-powered patient engagement and revenue system designed to help elective healthcare practices, especially plastic surgeons, capture every lead and prevent revenue loss from missed inquiries. The company offers an integrated AI front-office platform that automatically captures calls, texts, forms and social media messages, follows up with personalized outreach and generates prioritized daily action plans, enabling customers to maximize patient conversions, reduce lost revenue and optimize marketing spend with data-driven insights.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2026
- Employees
- 7
- Website
- runriviera.com/
- Ownership
- Privately Held (backing)
Riviera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Riviera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Riviera in its N-PORT filings yet. We sweep new filings monthly.